AAREY DRUGS & PHARMACEUTICALS
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr |
Equity - Authorised | ₹26 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Equity - Issued | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr |
Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr | ₹23 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹2.32 Cr | ₹2.32 Cr | ₹2.32 Cr | ₹2.32 Cr | ₹2.32 Cr |
Total Reserves | ₹90 Cr | ₹86 Cr | ₹73 Cr | ₹67 Cr | ₹61 Cr |
Securities Premium | ₹41 Cr | ₹41 Cr | ₹35 Cr | ₹35 Cr | ₹35 Cr |
Capital Reserves | ₹0.20 Cr | ₹0.20 Cr | ₹0.20 Cr | ₹0.20 Cr | ₹0.20 Cr |
Profit & Loss Account Balance | ₹48 Cr | ₹45 Cr | ₹38 Cr | ₹32 Cr | ₹26 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹90 Cr | ₹86 Cr | ₹73 Cr | ₹67 Cr | ₹61 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹117 Cr | ₹114 Cr | ₹99 Cr | ₹92 Cr | ₹87 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹4.36 Cr | ₹3.34 Cr | - | ₹0.02 Cr | ₹0.04 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹4.36 Cr | ₹3.34 Cr | - | ₹0.02 Cr | ₹0.04 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹1.42 Cr | ₹1.46 Cr | ₹1.56 Cr | ₹1.44 Cr | ₹1.49 Cr |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | ₹1.42 Cr | ₹1.46 Cr | ₹1.56 Cr | ₹1.44 Cr | ₹1.49 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | ₹1.81 Cr | - | - |
Total Non-Current Liabilities | ₹5.78 Cr | ₹4.80 Cr | ₹3.37 Cr | ₹1.46 Cr | ₹1.53 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹127 Cr | ₹110 Cr | ₹110 Cr | ₹78 Cr | ₹37 Cr |
Sundry Creditors | ₹127 Cr | ₹110 Cr | ₹110 Cr | ₹78 Cr | ₹37 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹2.18 Cr | ₹1.03 Cr | ₹0.78 Cr | ₹2.00 Cr | ₹0.38 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹2.18 Cr | ₹1.03 Cr | ₹0.78 Cr | ₹2.00 Cr | ₹0.38 Cr |
Short Term Borrowings | ₹33 Cr | ₹11 Cr | ₹18 Cr | ₹18 Cr | ₹16 Cr |
Secured ST Loans repayable on Demands | ₹33 Cr | ₹11 Cr | ₹17 Cr | ₹17 Cr | ₹16 Cr |
Working Capital Loans- Sec | ₹33 Cr | ₹11 Cr | ₹17 Cr | ₹17 Cr | ₹16 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-33 Cr | ₹-11 Cr | ₹-17 Cr | ₹-17 Cr | ₹-16 Cr |
Short Term Provisions | ₹5.28 Cr | ₹5.23 Cr | ₹1.66 Cr | ₹2.66 Cr | ₹3.86 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹5.06 Cr | ₹4.83 Cr | ₹1.66 Cr | ₹2.66 Cr | ₹3.86 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.22 Cr | ₹0.40 Cr | - | - | - |
Total Current Liabilities | ₹168 Cr | ₹127 Cr | ₹131 Cr | ₹100 Cr | ₹58 Cr |
Total Liabilities | ₹291 Cr | ₹245 Cr | ₹233 Cr | ₹194 Cr | ₹146 Cr |
ASSETS | |||||
Gross Block | ₹33 Cr | ₹32 Cr | ₹30 Cr | ₹27 Cr | ₹26 Cr |
Less: Accumulated Depreciation | ₹19 Cr | ₹18 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹12 Cr | ₹12 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | - |
Non Current Investments | ₹0.40 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.44 Cr | ₹0.44 Cr |
Long Term Investment | ₹0.40 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.44 Cr | ₹0.44 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.40 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.44 Cr | ₹0.44 Cr |
Long Term Loans & Advances | ₹6.37 Cr | ₹9.09 Cr | - | - | - |
Other Non Current Assets | ₹0.01 Cr | ₹2.40 Cr | - | - | ₹0.01 Cr |
Total Non-Current Assets | ₹21 Cr | ₹26 Cr | ₹15 Cr | ₹13 Cr | ₹13 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹29 Cr | ₹14 Cr | ₹18 Cr | ₹17 Cr | ₹21 Cr |
Raw Materials | ₹7.10 Cr | ₹4.92 Cr | ₹4.02 Cr | - | - |
Work-in Progress | ₹1.75 Cr | ₹0.26 Cr | ₹0.53 Cr | - | - |
Finished Goods | ₹11 Cr | ₹3.57 Cr | ₹2.68 Cr | - | - |
Packing Materials | - | - | - | - | - |
Stores ĆĀ and Spare | - | - | - | - | - |
Other Inventory | ₹9.27 Cr | ₹4.93 Cr | ₹11 Cr | ₹17 Cr | ₹21 Cr |
Sundry Debtors | ₹190 Cr | ₹136 Cr | ₹162 Cr | ₹96 Cr | ₹106 Cr |
Debtors more than Six months | ₹19 Cr | ₹21 Cr | ₹17 Cr | - | ₹8.88 Cr |
Debtors Others | ₹170 Cr | ₹115 Cr | ₹145 Cr | ₹96 Cr | ₹97 Cr |
Cash and Bank | ₹0.71 Cr | ₹0.19 Cr | ₹0.65 Cr | ₹0.50 Cr | ₹0.37 Cr |
Cash in hand | ₹0.70 Cr | ₹0.16 Cr | ₹0.01 Cr | - | - |
Balances at Bank | ₹0.01 Cr | ₹0.03 Cr | ₹0.64 Cr | ₹0.50 Cr | ₹0.37 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.81 Cr | ₹0.66 Cr | ₹2.81 Cr | ₹1.85 Cr | ₹1.04 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | ₹0.47 Cr | ₹0.47 Cr | ₹2.77 Cr | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | - | - | - | - |
Other current_assets | ₹0.34 Cr | ₹0.20 Cr | ₹0.04 Cr | ₹1.85 Cr | ₹1.04 Cr |
Short Term Loans and Advances | ₹50 Cr | ₹68 Cr | ₹34 Cr | ₹66 Cr | ₹4.59 Cr |
Advances recoverable in cash or in kind | ₹39 Cr | ₹66 Cr | ₹31 Cr | ₹61 Cr | ₹0.07 Cr |
Advance income tax and TDS | ₹0.84 Cr | ₹0.48 Cr | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹11 Cr | ₹1.41 Cr | ₹3.73 Cr | ₹4.64 Cr | ₹4.52 Cr |
Total Current Assets | ₹271 Cr | ₹219 Cr | ₹218 Cr | ₹181 Cr | ₹133 Cr |
Net Current Assets (Including Current Investments) | ₹102 Cr | ₹92 Cr | ₹88 Cr | ₹81 Cr | ₹75 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹291 Cr | ₹245 Cr | ₹233 Cr | ₹194 Cr | ₹146 Cr |
Contingent Liabilities | - | - | - | - | - |
Total Debt | ₹38 Cr | ₹14 Cr | ₹18 Cr | ₹18 Cr | ₹16 Cr |
Book Value | 45.34 | 43.85 | 41.29 | 38.50 | 36.02 |
Adjusted Book Value | 45.34 | 43.85 | 41.29 | 38.50 | 36.02 |
Compare Balance Sheet of peers of AAREY DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AAREY DRUGS & PHARMACEUTICALS | ₹143.1 Cr | 12% | -5.9% | 84.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AAREY DRUGS & PHARMACEUTICALS | 12% |
-5.9% |
84.1% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses